ACTU vs AZO · $49.0M cap vs P/E 21, rev $18.94B
Actuate Therapeutics, Inc. Common stock (ACTU) versus AutoZone Inc (AZO) — a side-by-side from cached financials, not a winner call.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
AutoZone Inc (AZO) is a auto parts company listed on NYSE.
ACTU does not have a complete income-statement cache yet.
Latest reported AZO revenue for 2025-08-30 was $18.94B. Net income was $2.50B. Revenue was up 2.4% from 2024-08-31 to 2025-08-30. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
ACTU currently screens at market cap $49.0M. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
Not investment advice. Open the ACTU and AZO stock pages for the full models.
Not investment advice.